Sensyne Health PLC (LON:SENS) has launched the first operational AI algorithm for coronavirus (COVID-19) patients built on its SENSE engine.
SYNE-OPS-1 was co-developed with the Chelsea & Westminster Hospital NHS Foundation Trust, which has now integrated the system and is using it to manage COVID-19 patients in its intensive care unit.
In a statement, Roger Chinn, chief medical officer at Chelsea & Westminster Hospital said: "The SYNE-OPS-1 algorithm has proved invaluable during this current wave of the pandemic. We are able to predict ventilator and non-mechanical support requirements in ICU, helping us to make best use of our expertise and resources."
SYNE-OPS-1 provides an hourly risk forecast of the expected number of future ICU admissions and the future demand for ventilators, based upon an analysis of clinical data on COVID-19 patients being admitted to hospital.
Patients’ vital signs and lab test results are transmitted to the SENSE clinical AI platform with the results presented on a dashboard for managers.
Lord Drayson, Sennsyne's CEO said: "The successful deployment of our first operational algorithm, developed in collaboration with our research partners at Chelsea and Westminster NHS Foundation Trust, is an important milestone for Sensyne.
“We aim to build a broad range of operational algorithms on our SENSE platform to help significantly improve the performance of health systems with the potential of generating a significant commercial return for Sensyne and our research partners."